ZNF638 and glioblastoma: To corroborate the translational potential of our findings, we established stable shRNA knockdown of ZNF638 in murine GBM cell lines that have been previously validated to recapitulate the intrinsic immunosuppressive characteristics of GBM and its tumor microenvironment with poor basal checkpoint presentation.